Option Care Health, Inc. (OPCH)
USD 22.78
(-2.73%)
USD 22.78
(-2.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.3 Billion USD | 9.06% |
| 2022 | 3.94 Billion USD | 14.72% |
| 2021 | 3.43 Billion USD | 13.39% |
| 2020 | 3.03 Billion USD | 31.26% |
| 2019 | 2.31 Billion USD | 225.91% |
| 2018 | 708.9 Million USD | -13.25% |
| 2017 | 817.19 Million USD | -12.66% |
| 2016 | 935.58 Million USD | -4.75% |
| 2015 | 982.22 Million USD | -0.19% |
| 2014 | 984.05 Million USD | 16.84% |
| 2013 | 842.19 Million USD | 27.1% |
| 2012 | 662.63 Million USD | -63.55% |
| 2011 | 1.81 Billion USD | 10.95% |
| 2010 | 1.63 Billion USD | 23.25% |
| 2009 | 1.32 Billion USD | -5.16% |
| 2008 | 1.4 Billion USD | 17.05% |
| 2007 | 1.19 Billion USD | 3.93% |
| 2006 | 1.15 Billion USD | 7.38% |
| 2005 | 1.07 Billion USD | 70.22% |
| 2004 | 630.51 Million USD | 7.09% |
| 2003 | 588.77 Million USD | 2.11% |
| 2002 | 576.59 Million USD | 26.27% |
| 2001 | 456.64 Million USD | 23.49% |
| 2000 | 369.79 Million USD | -2.02% |
| 1999 | 377.42 Million USD | -16.33% |
| 1998 | 451.1 Million USD | 86.17% |
| 1997 | 242.3 Million USD | -14.44% |
| 1996 | 283.2 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.22 Billion USD | 7.08% |
| 2024 Q1 | 1.14 Billion USD | 1.93% |
| 2024 Q3 | 1.27 Billion USD | 4.19% |
| 2023 FY | 4.3 Billion USD | 9.06% |
| 2023 Q1 | 1.01 Billion USD | -1.11% |
| 2023 Q2 | 1.06 Billion USD | 5.24% |
| 2023 Q3 | 1.09 Billion USD | 2.24% |
| 2023 Q4 | 1.12 Billion USD | 2.87% |
| 2022 Q3 | 1.02 Billion USD | 4.09% |
| 2022 Q4 | 1.02 Billion USD | 0.62% |
| 2022 Q1 | 915.78 Million USD | -1.23% |
| 2022 Q2 | 980.82 Million USD | 7.1% |
| 2022 FY | 3.94 Billion USD | 14.72% |
| 2021 Q3 | 891.93 Million USD | 3.68% |
| 2021 Q4 | 927.19 Million USD | 3.95% |
| 2021 Q1 | 759.23 Million USD | -5.65% |
| 2021 FY | 3.43 Billion USD | 13.39% |
| 2021 Q2 | 860.27 Million USD | 13.31% |
| 2020 Q3 | 781.6 Million USD | 5.5% |
| 2020 Q1 | 705.44 Million USD | -2.13% |
| 2020 Q2 | 740.84 Million USD | 5.02% |
| 2020 Q4 | 804.71 Million USD | 2.96% |
| 2020 FY | 3.03 Billion USD | 31.26% |
| 2019 Q1 | 178.95 Million USD | -2.51% |
| 2019 Q4 | 720.77 Million USD | 17.03% |
| 2019 Q3 | 615.88 Million USD | 221.58% |
| 2019 Q2 | 191.51 Million USD | 7.02% |
| 2019 FY | 2.31 Billion USD | 225.91% |
| 2018 Q4 | 183.56 Million USD | 1.44% |
| 2018 Q2 | 175.78 Million USD | 4.27% |
| 2018 Q1 | 168.58 Million USD | -7.67% |
| 2018 FY | 708.9 Million USD | -13.25% |
| 2018 Q3 | 180.96 Million USD | 2.94% |
| 2017 FY | 817.19 Million USD | -12.66% |
| 2017 Q2 | 218.1 Million USD | 0.14% |
| 2017 Q3 | 198.69 Million USD | -8.9% |
| 2017 Q4 | 182.58 Million USD | -8.11% |
| 2017 Q1 | 217.81 Million USD | -9.29% |
| 2016 FY | 935.58 Million USD | -4.75% |
| 2016 Q3 | 224.54 Million USD | -3.41% |
| 2016 Q2 | 232.46 Million USD | -2.52% |
| 2016 Q1 | 238.46 Million USD | -2.17% |
| 2016 Q4 | 240.12 Million USD | 6.94% |
| 2015 Q2 | 262.36 Million USD | 0.26% |
| 2015 Q3 | 247.22 Million USD | -5.77% |
| 2015 Q4 | 243.74 Million USD | -1.41% |
| 2015 FY | 982.22 Million USD | -0.19% |
| 2015 Q1 | 261.68 Million USD | 3.15% |
| 2014 Q4 | 253.67 Million USD | 3.98% |
| 2014 Q2 | 247.12 Million USD | 3.12% |
| 2014 FY | 984.05 Million USD | 16.84% |
| 2014 Q1 | 239.64 Million USD | -1.59% |
| 2014 Q3 | 243.95 Million USD | -1.28% |
| 2013 Q3 | 208.87 Million USD | 9.51% |
| 2013 Q4 | 243.51 Million USD | 16.58% |
| 2013 FY | 842.19 Million USD | 27.1% |
| 2013 Q1 | 199.07 Million USD | 10.14% |
| 2013 Q2 | 190.73 Million USD | -4.19% |
| 2012 Q2 | 155.9 Million USD | 0.17% |
| 2012 Q4 | 180.73 Million USD | 6.09% |
| 2012 Q1 | 155.63 Million USD | -67.8% |
| 2012 FY | 662.63 Million USD | -63.55% |
| 2012 Q3 | 170.36 Million USD | 9.28% |
| 2011 Q2 | 441.4 Million USD | 0.48% |
| 2011 Q3 | 454.02 Million USD | 2.86% |
| 2011 Q1 | 439.29 Million USD | -2.46% |
| 2011 Q4 | 483.3 Million USD | 6.45% |
| 2011 FY | 1.81 Billion USD | 10.95% |
| 2010 Q2 | 412.03 Million USD | 22.97% |
| 2010 FY | 1.63 Billion USD | 23.25% |
| 2010 Q4 | 450.37 Million USD | 2.09% |
| 2010 Q1 | 335.06 Million USD | -1.9% |
| 2010 Q3 | 441.15 Million USD | 7.07% |
| 2009 Q3 | 333.47 Million USD | 1.44% |
| 2009 FY | 1.32 Billion USD | -5.16% |
| 2009 Q4 | 341.55 Million USD | 2.42% |
| 2009 Q2 | 328.74 Million USD | 0.92% |
| 2009 Q1 | 325.74 Million USD | -11.14% |
| 2008 FY | 1.4 Billion USD | 17.05% |
| 2008 Q4 | 366.57 Million USD | 1.99% |
| 2008 Q1 | 327.47 Million USD | 6.23% |
| 2008 Q2 | 348.44 Million USD | 6.4% |
| 2008 Q3 | 359.42 Million USD | 3.15% |
| 2007 Q1 | 296.34 Million USD | 1.4% |
| 2007 FY | 1.19 Billion USD | 3.93% |
| 2007 Q4 | 308.25 Million USD | 3.39% |
| 2007 Q3 | 298.13 Million USD | 1.06% |
| 2007 Q2 | 295 Million USD | -0.45% |
| 2006 Q1 | 299.71 Million USD | -1.49% |
| 2006 Q2 | 279.58 Million USD | -6.72% |
| 2006 Q3 | 280.91 Million USD | 0.48% |
| 2006 Q4 | 292.24 Million USD | 4.03% |
| 2006 FY | 1.15 Billion USD | 7.38% |
| 2005 FY | 1.07 Billion USD | 70.22% |
| 2005 Q1 | 188.39 Million USD | 12.92% |
| 2005 Q2 | 286.61 Million USD | 52.13% |
| 2005 Q3 | 293.97 Million USD | 2.57% |
| 2005 Q4 | 304.24 Million USD | 3.49% |
| 2004 Q2 | 154.12 Million USD | 4.1% |
| 2004 Q3 | 161.49 Million USD | 4.78% |
| 2004 Q4 | 166.84 Million USD | 3.31% |
| 2004 Q1 | 148.05 Million USD | 9.07% |
| 2004 FY | 630.51 Million USD | 7.09% |
| 2003 Q1 | 162.15 Million USD | 7.61% |
| 2003 Q4 | 135.74 Million USD | 4.71% |
| 2003 Q3 | 129.64 Million USD | -19.59% |
| 2003 Q2 | 161.23 Million USD | -0.57% |
| 2003 FY | 588.77 Million USD | 2.11% |
| 2002 Q3 | 138.53 Million USD | 2.06% |
| 2002 Q4 | 150.68 Million USD | 8.77% |
| 2002 Q2 | 135.73 Million USD | -10.5% |
| 2002 Q1 | 151.65 Million USD | 22.42% |
| 2002 FY | 576.59 Million USD | 26.27% |
| 2001 Q3 | 119.88 Million USD | 12.2% |
| 2001 Q4 | 123.87 Million USD | 3.33% |
| 2001 Q1 | 106.03 Million USD | 6.14% |
| 2001 Q2 | 106.85 Million USD | 0.77% |
| 2001 FY | 456.64 Million USD | 23.49% |
| 2000 Q2 | 95.69 Million USD | 7.39% |
| 2000 Q4 | 99.89 Million USD | 17.39% |
| 2000 Q3 | 85.1 Million USD | -11.07% |
| 2000 FY | 369.79 Million USD | -2.02% |
| 2000 Q1 | 89.1 Million USD | -20.6% |
| 1999 Q2 | 88.9 Million USD | 18.69% |
| 1999 Q4 | 112.22 Million USD | 10.67% |
| 1999 Q3 | 101.4 Million USD | 14.06% |
| 1999 Q1 | 74.9 Million USD | -41.25% |
| 1999 FY | 377.42 Million USD | -16.33% |
| 1998 Q4 | 127.5 Million USD | 10.2% |
| 1998 FY | 451.1 Million USD | 86.17% |
| 1998 Q1 | 98 Million USD | 26.78% |
| 1998 Q2 | 109.9 Million USD | 12.14% |
| 1998 Q3 | 115.7 Million USD | 5.28% |
| 1997 Q4 | 77.3 Million USD | 60.04% |
| 1997 Q3 | 48.3 Million USD | 5.46% |
| 1997 Q2 | 45.8 Million USD | -35.31% |
| 1997 Q1 | 70.8 Million USD | -5.22% |
| 1997 FY | 242.3 Million USD | -14.44% |
| 1996 FY | 283.2 Million USD | 0.0% |
| 1996 Q1 | 67.7 Million USD | 0.0% |
| 1996 Q4 | 74.7 Million USD | 2.05% |
| 1996 Q3 | 73.2 Million USD | 8.12% |
| 1996 Q2 | 67.7 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | -46.9% |
| Addus HomeCare Corporation | 1.05 Billion USD | -306.397% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -2095.993% |
| Amedisys, Inc. | 2.23 Billion USD | -92.379% |
| American Oncology Network, Inc. | 1.27 Billion USD | -236.333% |
| Astrana Health, Inc. | 1.38 Billion USD | -210.265% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -127.011% |
| IMAC Holdings, Inc. | 5.19 Million USD | -82684.76% |
| biote Corp. | 185.36 Million USD | -2221.064% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -13626.282% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | -113.015% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -589.156% |
| The Ensign Group, Inc. | 3.72 Billion USD | -15.364% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -157.41% |
| InnovAge Holding Corp. | 763.85 Million USD | -463.238% |
| Assure Holdings Corp. | 255 Thousand USD | -1687085.882% |
| The Joint Corp. | 117.69 Million USD | -3555.444% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -307.546% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -41434.169% |
| ModivCare Inc. | 2.75 Billion USD | -56.382% |
| NewGenIvf Group Limited | 5.13 Million USD | -83665.495% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -34121.425% |
| P3 Health Partners Inc. | 1.26 Billion USD | -239.735% |
| P3 Health Partners Inc. | 1.26 Billion USD | -239.735% |
| The Pennant Group, Inc. | 544.89 Million USD | -689.575% |
| Surgery Partners, Inc. | 2.74 Billion USD | -56.83% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -77909.278% |
| Talkspace, Inc. | 150.04 Million USD | -2767.356% |
| Talkspace, Inc. | 150.04 Million USD | -2767.356% |
| The Oncology Institute, Inc. | 324.23 Million USD | -1226.899% |
| The Oncology Institute, Inc. | 324.23 Million USD | -1226.899% |